| CAS号 | 名称 | 物化性质 | 分子式 | 分子量 |
| 839730-93-7 | Cathepsin D and E FRET Substrate
| |
C85H122N22O19 | 1756.1 |
| 41594-08-5 | C-Peptide 2,rat
| |
C135H222N38O49 | 3161.4 |
| 1204329-34-9 | BI-9627
| |
C16N4O2F3H19 | 356.34 |
| 183241-31-8 | BA1TFA
BA1 TFA | |
C57H76N14O11 | 1133.3 |
| 73724-75-1 | Adrenocorticotropic Hormone(ACTH)(18-39), human TFA
| |
C114H166F3N27O38 | 2579.69 |
| 189684-54-6 | Ac-VEID-pNA TFA
| 密度：1.327±0.06 g/cm3(Predicted)
沸点：1086.6±65.0 °C(Predicted)
|
C28H40N6O11 | 636.65 |
| 189684-53-5 | Ac-VDVAD-pNA
| |
C29H41N7O12 | 679.680 |
| 2828433-24-3 | 4-氨基-1-((R)-6-氨基-2-((R)-2-((R)-2-((R)-2-氨基-3-苯基丙酰胺基)-3-苯基丙酰胺基)- 4-甲基戊胺基)己酰基)哌啶-4-羧酸三氟乙酸盐
4-Amino-1-((R)-6-amino-2-((R)-2-((R)-2-((R)-2-amino-3-phenylpropanamido)-3-phenylpropanamido)-4-methylpentanamido)hexanoyl)piperidine-4-carboxylic acid trifluoroacetate | |
C38H54F3N7O8 | 793.87 |
| 402750-12-3 | 3X Flag Peptide Trifluoroacetate
| |
C120H169N31O49S | 2861.87 |
| 115472-96-3 | 32a-Glycine-calcitonin (Salmon)
| |
C147H242N44O50S2 | 3489.889 |
| 11023-94-2 | 1-(3-BETA-D-吡喃葡萄糖基-2,4,6-三羟基苯基)-3-(4-羟基苯基)-1-丙酮
Nothofagin | |
C21H24O10 | 436.41 |
| 158848-32-9 | ({1-[2-(5-氟-1H-吲哚-3-基)乙基]-4-甲氧基-4-哌啶基}甲基)(苯基)锍醇)
GR 159897 | |
C23H27FN2O2S | 414.54 |
| 957780-54-0 | (S)-3-((S)-2-((((9H-芴-9-基)甲氧基)羰基)氨基)-6-((叔-丁氧羰基)氨基)己酰)-2,2-二甲基噁唑烷-4-羧酸
Fmoc-Lys(Boc)-Ser[Psi(Me,Me)Pro]-OH | |
C32H41N3O8 | 595.68 |
| 1821378-64-6 | (S)-3-((S)-2-((((9H-芴-9-基)甲氧基)羰基)氨基)-5-氧代-5-(三苯甲基氨基)戊酰基)-2,2-二甲基恶唑烷-4-羧酸
Fmoc-Gln(Trt)-Ser(psi(Me,Me)pro)-OH | |
C45H43N3O7 | 737.84 |
| 1000164-43-1 | (S)-3-((S)-2-((((9H-芴-9-基)甲氧基)羰基)氨基)-3-(叔丁氧基)丙酰基)-2,2-二甲基恶唑烷-4-羧酸
Fmoc-Ser(tBu)-Ser(PSiMe,MePro)-OH | 密度：1.240±0.06 g/cm3(Predicted)
沸点：716.2±60.0 °C(Predicted)
|
C28H34N2O7 | 510.58 |
| 1147996-34-6 | (S)-3-((2S,3S)-2-((((9H-芴-9-基)甲氧基)羰基)氨基)-3-甲基戊酰基)-2,2-二甲基恶唑烷-4-羧酸
Fmoc-Ile-Ser(psiMe,MePro)-OH | 密度：1.234±0.06 g/cm3(Predicted)
沸点：695.1±55.0 °C(Predicted)
|
C27H32N2O6 | 480.55 |
| 866044-63-5 | (S)-2-(2-((((9H-芴-9-基)甲氧基)羰基)氨基)-5-(叔丁氧基)-5-氧代戊酰胺基)乙酸
(S)-2-(2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-5-(tert-butoxy)-5-oxopentanamido)acetic acid | |
C26H30N2O7 | 482.53 |
| 82007-05-4 | (S)-2-(2-((((9H-芴-9-基)甲氧基)羰基)氨基)-4-甲基戊酰胺基)乙酸
Fmoc-Leu-Gly-OH | 密度：1.237±0.06 g/cm3(Predicted)
熔点：149-150 °C
沸点：682.5±45.0 °C(Predicted)
|
C23H26N2O5 | 410.46 |
| 7369-79-1 | (S)-2-((S)-2,6-二氨基己二酸)-4-甲基戊酸
H-Lys-Leu-OH | |
C12H25N3O3 | 259.35 |
| 124215-72-1 | (S)-2-((R)-2-((叔丁氧羰基)氨基)-3-苯基丙酰胺基)-3-苯基丙酸
(S)-2-((R)-2-((tert-Butoxycarbonyl)amino)-3-phenylpropanamido)-3-phenylpropanoic acid | 密度：1.194±0.06 g/cm3(Predicted)
沸点：660.3±55.0 °C(Predicted)
|
C23H28N2O5 | 412.48 |
| 187794-49-6 | (S)-12-苄基-2,2-二甲基-4,7,10,13-四氧代-3-氧杂-5,8,11,14-四氮杂十六烷-16-酸
(S)-12-Benzyl-2,2-dimethyl-4,7,10,13-tetraoxo-3-oxa-5,8,11,14-tetraazahexadecan-16-oic acid | |
C20H28N4O7 | 436.46 |
| 2828433-15-2 | (S)-1-((S)-2-((S)-2-(2-((S)-1-((S)-1-((S)-2-氨基-5-胍基戊酰基))吡咯烷-2-羰基)吡咯烷-2-甲酰胺基)乙酰胺基)-3-苯基丙酰胺基)-3-羟基丙酰基)吡咯烷-2-羧酸三氟乙酸盐
H-Arg-Pro-PRO-Gly-Phe-Ser-Pro-OH trifluoroacetate | |
C37H53F3N10O11 | 870.87 |
| 957780-59-5 | (5R)-3-[(2S)-2-[[芴甲氧羰基]氨基]-1,4-二氧代-4-[(三苯基甲基)氨基]丁基]-2,2,5-三甲基-4-恶唑烷羧酸
Fmoc-asn(trt)-thr(psime,mepro)-oh | |
C45H43N3O7 | 737.84 |
| 957780-56-2 | (4S,5R)-3-((S)-2-((((9H-芴-9-基)甲氧基)羰基)氨基)-5-(叔丁氧基)-5-氧代戊酰基)-2,2,5-三甲基恶唑烷-4-羧酸
Fmoc-glu(otbu)-thr(psi(Me ,Me)pro)-OH | 密度：1.226±0.06 g/cm3(Predicted)
沸点：760.5±60.0 °C(Predicted)
|
C31H38N2O8 | 566.64 |
| 1196703-48-6 | (4S,5R)-3-((S)-2-((((9H-芴-9-基)甲氧基)羰基)氨基)-3-苯基丙酰基)-2,2,5-三甲基恶唑烷-4-羧酸
Fmoc-Phe-Thr(psime,MePro)-OH | 密度：1.258±0.06 g/cm3(Predicted)
沸点：764.4±60.0 °C(Predicted)
|
C31H32N2O6 | 528.60 |
| 1266350-99-5 | (4S,5R)-3-((S)-2-((((9H-芴-9-基)甲氧基)羰基)氨基)-3-(叔丁氧基)丙酰基)-2,2,5-三甲基恶唑烷-4-羧酸
Fmoc-Ser(tBu)-Thr(Psi(Me,Me)pro)-OH | |
C29H36N2O7 | 524.61 |
| 920519-31-9 | (4S,5R)-3-((S)-2-((((9H-芴-9-基)甲氧基)羰基)氨基)-3-(4-(叔丁氧基)苯基)丙酰基)-2,2,5-三甲基恶唑烷-4-羧酸
Fmoc-Tyr(tBu)-Thr(psiMe,Mepro)-OH | 密度：1.217±0.06 g/cm3(Predicted)
沸点：796.2±60.0 °C(Predicted)
|
C35H40N2O7 | 600.70 |
| 936707-21-0 | (4S,5R)-3-((S)-2-((((9H-芴-9-基)甲氧基)羰基)氨基)-3-(1-(叔丁氧基羰基)-1H-吲哚-3-基)丙酰基)-2,2,5-三甲基恶唑烷-4-羧酸
Fmoc-Trp(Boc)-Thr(psi(Me,Me)pro)-OH | |
C38H41N3O8 | 667.75 |
| 1676104-73-6 | (4S,5R)-3-((2S,3R)-2-((((9H-芴-9-基)甲氧基)羰基)氨基)-3-(叔丁氧基)丁酰基)-2,2,5-三甲基恶唑烷-4-羧酸
Fmoc-Thr(tBu)-Thr(Psi(Me, Me)pro)-OH | |
C30H38N2O7 | 538.63 |
| 1095952-22-9 | (4S)-3-[2-[[芴甲氧羰基]氨基]乙酰基]-2,2-二甲基-4-恶唑烷羧酸
Fmoc-Glu(OtBu)-Thr(Psi(Me,Me)Pro)-OH | 沸点：683.6±55.0 °C at 760 mmHg
|
C23H24N2O6 | 424.45 |
| 110570-93-9 | Myomodulin A trifluoroacetate salt
| |
C36H67N11O8S2 | 846.12 |
| 194935-38-1 | 前列腺素E2乙醇酰胺
Prostaglandin E2 Ethanolamide | 密度：1.134±0.06 g/cm3(Predicted)
沸点：611.5±55.0 °C(Predicted)
|
C22H37NO5 | 395.5 |
| 1055703-96-2 | (1R,2R)-1,2-双(2-氯苯基)乙烷-1,2-二胺
1,2-Ethanediamine, 1,2-bis(2-chlorophenyl)-, (1R,2R)- | 密度：1.303±0.06 g/cm3(Predicted)
沸点：404.3±40.0 °C(Predicted)
|
C14H14Cl2N2 | 281.18 |
| 135251-85-3 | D-萤光素乙酯
Ethyl (S)-2-(6-hydroxybenzo[d]thiazol-2-yl)-4,5-dihydrothiazole-4-carboxylate | |
C13H12N2O3S2 | 308.38 |
| 885481-03-8 | 1-(3',6'-双(乙基氨基)-2',7'-二甲基-3-氧代螺[异吲哚啉-1,9'-氧杂蒽]-2-基)-3-苯基硫脲
1-(3',6'-Bis(ethylamino)-2',7'-dimethyl-3-oxospiro[isoindoline-1,9'-xanthen]-2-yl)-3-phenylthiourea | |
C33H33N5O2S | 563.71 |
| 84890-01-7 | 1,5-二(2-羟基-5-氯苯)-3-氰基甲月替
HCPCF | |
| |
| 1402423-29-3 | 糖酵素
Glyco-diosgenin | |
C56H92O25 | 1165.31 |
| 349477-49-2 | 7-环己基-1-庚基-β-D-麦芽糖苷
7-Cyclohexyl-1-Heptyl-β-D-Maltoside | |
C25H46O11 | 522.5 |
| 3376-50-9 | 2,4,6-三甲基吡啶氮氧化物
2,4,6-Trimethylpyridine 1-oxide | |
C8H11NO | 137.18 |
| 2743786-20-9 | 4-(3-哌啶基)恶唑;盐酸盐
4-(3-piperidyl)oxazole;hydrochloride | |
C8H13ClN2O | 188.6541 |
| 1537892-36-6 | 马来酰亚胺-三聚乙二醇-琥珀酰亚胺酯
Mal-PEG3-NHS ester | |
C17H22N2O9 | 398.36 |
| 1380723-44-3 | 阿特珠单抗
Atezolizumab | |
| |
| 178744-28-0 | 甲氧基-PEG-N-二硬脂酰磷脂酰乙酰胺
mPEG-DSPE | |
(C2H4O)nC44H88NO9P | |
| 122375-06-8 | 琥珀酰亚胺酯-聚乙二醇-琥珀酰亚胺酯
NHS-PEG-NHS | |
| |
| 1174395-19-7 | 布罗达单抗
Brodalumab | |
| |
| 2072873-06-2 | 信迪利单抗
Sintilimab | |
| |
| 1190924-04-9 | 二硬脂酰基磷脂酰乙醇胺-聚乙二醇-马来酰亚胺
DSPE-PEG-Mal | |
| |
| 745013-59-6 | Tremelimumab
| |
| |
| 1628113-16-5 | SPDB-sulfo
| |
C13H14N2O7S3 | 406.45 |
| 541502-14-1 | Siltuximab
| |
| |
